RE, K., N, S., S, C., G, K., Y, S., R, G., & ME, H. (2017). The ABC7 regimen: A new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy. Dove Medical Press.
Style de citation Chicago (17e éd.)RE, Kast, Skuli N, Cos S, Karpel-Massler G, Shiozawa Y, Goshen R, et Halatsch ME. The ABC7 Regimen: A New Approach to Metastatic Breast Cancer Using Seven Common Drugs to Inhibit Epithelial-to-mesenchymal Transition and Augment Capecitabine Efficacy. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)RE, Kast, et al. The ABC7 Regimen: A New Approach to Metastatic Breast Cancer Using Seven Common Drugs to Inhibit Epithelial-to-mesenchymal Transition and Augment Capecitabine Efficacy. Dove Medical Press, 2017.